Through recent preliminary experiments, we have found that CML-BSA can also promote VSMC proliferation and mitochondrial division, dramatically increase the level of Drp1, and down-regulate Mfn2 expression; these effects of CML-BSA were effectively reversed by Mdivi-1. The gene discussed is MFN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.